Reasons for and Time to Discontinuation of Rimonabant Therapy

  • M.J.C. Willemen
  • , A.K. Mantel-Teeuwisse
  • , Y. Buggy
  • , D Layton
  • , S.M.J.M. Strauss
  • , H.G.M. Leufkens
  • , A.C.G. Egberts

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)1147-1158
Number of pages12
JournalDrug Safety
Volume35
Issue number12
Publication statusPublished - 2012

Cite this